 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
FIRST REGULAR SESSION-2019
Legislative Document No. 1325
S.P. 413 In Senate,  March  19, 2019
An Act  To Allow Workplace Substance  Use Testing for Fentanyl, 
Hydromorphone, Hydrocodone, Oxycodone and  Oxymorphone Use  
at the Employer's  Discretion
Reference to the Committee on Labor and Housing suggested and  ordered printed.
DAREK M.  GRANT
Secretary of the Senate
Presented by Senator KEIM of Oxford.
Cosponsored by Senators:  GUERIN of  Penobscot, MOORE  of Washington, Representatives: 
JAVNER of Chester, O'CONNOR  of Berwick, PERRY of Calais.

Page 1 - 129LR1025(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  26 MRSA ยง691 is enacted to read:
3ยง691.  Testing for fentanyl, hydromorphone, hydrocodone, oxycodone and 
4oxymorphone
5Notwithstanding any other provision of law, an employer may test an employee or an 
6applicant for employment for fentanyl, hydromorphone, hydrocodone, oxycodone and 
7oxymorphone use during any substance use test administered by the employer.
8SUMMARY
9This bill allows an employer to test an employee or an applicant for employment for 
10fentanyl, hydromorphone, hydrocodone, oxycodone and oxymorphone use during any 
11substance use test administered by the employer.
